To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene BTBD6TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
184 supporting clones for gene BTBD6 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI823792 pooled brain, lung, testis .a 1 to 338 1 to 333   tiling clone,   333/333
(100 %)
6 diff
(98.2 %id)
AI380621 B-cell, chronic lymphotic leukemia .a 64 to 349 286 to 1   tiling clone,   286/286
(100 %)
0 diff
(100 %id)
BF439691 pooled .a 342 to 925 1 to 584   tiling clone, Submitted on the opposite strand 584/584
(100 %)
0 diff
(100 %id)
BM457989 leiomyosarcoma, uterus .a 343 to 933 590 to 1     Submitted on the opposite strand 590/590
(100 %)
13 diff
(97.8 %id)
AW025207 Kidney .a 364 to 762 1 to 399     Submitted on the opposite strand 399/399
(100 %)
0 diff
(100 %id)
BQ883051 dorsal root ganglia .a 533 to 1308 18 to 805       788/993
(79 %)
31 diff
(96.9 %id)
BI914610 brain .a 536 to 1384 1 to 846       846/846
(100 %)
12 diff
(98.6 %id)
TI_57240885   .a 536 to 1384 33 to 878       846/878
(96 %)
17 diff
(98.1 %id)
CT003681 T-Lymphocytes .a 577 to 847 1 to 271       271/271
(100 %)
2 diff
(99.3 %id)
CV572012 cornea, eye .a 584 to 1151 1 to 568       568/568
(100 %)
2 diff
(99.7 %id)
BU500287   .a 823 to 1683 11 to 883       873/884
(98 %)
25 diff
(97.2 %id)
BG391618 embryonal carcinoma, cell line, testis .a 827 to 1265 1 to 438       438/438
(100 %)
1 diff
(99.8 %id)
BG696334 skin .a 840 to 1701 1 to 868       868/995
(87 %)
15 diff
(98.5 %id)
BG339026 leiomyosarcoma cell line, uterus .a 868 to 1546 1 to 678       678/679
(99 %)
2 diff
(99.8 %id)
BG575999 breast, mammary adenocarcinoma, cell line .a 877 to 1265 1 to 389       389/389
(100 %)
0 diff
(100 %id)
CD106506 brain, Pituitary .a 892 to 1745 23 to 877   tiling clone,   855/877
(97 %)
6 diff
(99.4 %id)
AA344590 gall bladder .a 926 to 1201 1 to 275       275/275
(100 %)
4 diff
(98.6 %id)
AA262845 germinal center B cell .a 930 to 1336 1 to 409       409/409
(100 %)
6 diff
(98.6 %id)
CD242378 brain, Pituitary .a 937 to 1685 15 to 765       751/878
(85 %)
9 diff
(99.0 %id)
AA196288   .a 975 to 1375 1 to 397     Submitted on the opposite strand 397/397
(100 %)
4 diff
(99.0 %id)
BF795270 lymph, lymphoma, cell line .a 981 to 1265 11 to 296       286/296
(96 %)
6 diff
(98.0 %id)
BM453172 leiomyosarcoma, uterus .a 1014 to 1858 1 to 856       856/982
(87 %)
19 diff
(98.1 %id)
BG315442   .a 1078 to 1270 1 to 192       192/192
(100 %)
4 diff
(98.0 %id)
BU933720 mixed (pool of 40 RNAs) .a 1119 to 1903 1 to 794       794/798
(99 %)
21 diff
(97.4 %id)
BM700130 eye, lens .a 1121 to 1697 1 to 577   fully sequenced,   577/577
(100 %)
0 diff
(100 %id)
CA487439   .a 1145 to 2010 1 to 875       875/879
(99 %)
10 diff
(98.9 %id)
BF364900 nervous_normal .a 1146 to 1707 563 to 2       562/563
(99 %)
0 diff
(100 %id)
CV570714 cornea, eye .a 1160 to 1781 1 to 622       622/622
(100 %)
0 diff
(100 %id)
AA374366 lung .a 1205 to 1514 1 to 309       309/309
(100 %)
5 diff
(98.4 %id)
BG026269 Bone, osteosarcoma, cell line .a 1212 to 1265 1 to 54       54/54
(100 %)
0 diff
(100 %id)
H26531 breast .a 1216 to 1588 391 to 12     Submitted on the opposite strand 380/459
(82 %)
0 diff
(100 %id)
AA558873 Prostate, prostatic intraepithelial neoplasia - highgrade .a 1218 to 1471 251 to 1       251/251
(100 %)
7 diff
(97.3 %id)
H14458 breast .a 1231 to 1585 358 to 1     Submitted on the opposite strand 358/359
(99 %)
10 diff
(97.3 %id)
BG679156 skin, squamous cell carcinoma .a 1255 to 2104 1 to 850       850/852
(99 %)
20 diff
(97.7 %id)
CF455354 peripheral nervous system .a 1255 to 1937 1 to 682       682/683
(99 %)
2 diff
(99.8 %id)
BQ214055 embryonal carcinoma, cell line, testis .a 1270 to 2145 1 to 898       898/899
(99 %)
34 diff
(96.3 %id)
BG031015 breast, mammary adenocarcinoma, cell line .a 1294 to 2158 1 to 853       853/858
(99 %)
34 diff
(96.1 %id)
CB132544 Liver .a 1294 to 1727 1 to 434       434/434
(100 %)
0 diff
(100 %id)
BG031282 breast, mammary adenocarcinoma, cell line .a 1295 to 2033 1 to 748       748/1181
(63 %)
20 diff
(98.4 %id)
AA360060 lung .a 1306 to 1605 1 to 299       299/299
(100 %)
1 diff
(99.7 %id)
AW959703   .a 1307 to 1870 1 to 563       563/565
(99 %)
10 diff
(98.3 %id)
BQ928269 epidermoid carcinoma, cell line, lung .a 1308 to 2256 1 to 953       953/953
(100 %)
19 diff
(98.1 %id)
R78236 placenta .a 1331 to 1812 486 to 1     Submitted on the opposite strand 486/489
(99 %)
27 diff
(94.5 %id)
AA112222 muscle, skeletal muscle .a 1345 to 1730 1 to 388       388/388
(100 %)
15 diff
(96.2 %id)
BU597624 mixed (pool of 40 RNAs) .a 1386 to 2119 1 to 742       742/841
(88 %)
16 diff
(98.1 %id)
BM693745 eye, lens .a 1406 to 1945 1 to 540   fully sequenced,   540/540
(100 %)
0 diff
(100 %id)
CB243619 Human Lung Epithelial cells, lung .a 1418 to 2257 854 to 16   tiling clone, AAA   839/839
(100 %)
3 diff
(99.7 %id)
CA390863 eye, RPE/choroid .a 1419 to 2048 1 to 630       630/630
(100 %)
0 diff
(100 %id)
TI_149312370   .a 1429 to 2254 909 to 95   AAA   815/929
(87 %)
12 diff
(98.8 %id)
BF093769 uterus .a 1434 to 1630 1 to 197       197/197
(100 %)
0 diff
(100 %id)
BQ220494 embryonal carcinoma, cell line, testis .a 1459 to 2254 845 to 43   AAA Submitted on the opposite strand 803/843
(95 %)
22 diff
(97.4 %id)
BF928562 nervous_tumor .a 1470 to 2001 538 to 5     Submitted on the opposite strand 534/538
(99 %)
0 diff
(100 %id)
BI029837 marrow .a 1470 to 2024 554 to 1       554/554
(100 %)
1 diff
(99.9 %id)
BQ331338 lung_tumor .a 1485 to 1753 54 to 325       272/331
(82 %)
18 diff
(94.6 %id)
BC006414 Uterus, endometrium adenocarcinoma .a 1485 to 2254 1 to 770   available from MGC, AAA   770/770
(100 %)
0 diff
(100 %id)
BE379373 endometrium, adenocarcinoma cell line, uterus .a 1486 to 2256 15 to 777   available from MGC,   763/990
(77 %)
6 diff
(99.4 %id)
BQ015224 Chondrosarcoma, Left Pubic Bone .a 1499 to 2257 769 to 16   AAA   754/754
(100 %)
7 diff
(99.1 %id)
BF726235 eye, lens .a 1515 to 2048 11 to 544       534/544
(98 %)
6 diff
(98.9 %id)
BF928572 nervous_tumor .a 1530 to 1950 446 to 24     Submitted on the opposite strand 423/446
(94 %)
0 diff
(100 %id)
BU581448 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .a 1533 to 2059 1 to 527       527/527
(100 %)
0 diff
(100 %id)
BG574248 breast, mammary adenocarcinoma, cell line .a 1546 to 2249 1 to 702   AAA   702/702
(100 %)
4 diff
(99.5 %id)
BE717758 head_neck .a 1565 to 2000 12 to 448       437/458
(95 %)
5 diff
(99.0 %id)
BE717802 head_neck .a 1565 to 1976 419 to 3       417/438
(95 %)
0 diff
(100 %id)
BE717820 head_neck .a 1565 to 1952 394 to 6       389/410
(94 %)
0 diff
(100 %id)
BE830386 lung_tumor .a 1565 to 2000 9 to 444       436/445
(97 %)
3 diff
(99.4 %id)
BE837678 prostate_normal .a 1565 to 1974 411 to 1       411/419
(98 %)
3 diff
(99.3 %id)
BE837766 prostate_normal .a 1565 to 2000 8 to 440       433/450
(96 %)
7 diff
(98.5 %id)
BE830471 lung_tumor .a 1568 to 1860 1 to 293       293/293
(100 %)
12 diff
(96.0 %id)
BE837829 prostate_normal .a 1574 to 2000 1 to 425       425/435
(97 %)
3 diff
(99.4 %id)
BQ231758 embryonal carcinoma, cell line, testis .a 1576 to 2257 16 to 697   AAA   682/697
(97 %)
5 diff
(99.3 %id)
CX786755 human embryonic stem cells .a 1580 to 2254 711 to 37   AAA Submitted on the opposite strand 675/675
(100 %)
19 diff
(97.2 %id)
BE837626 prostate_normal .a 1585 to 2000 1 to 425       425/435
(97 %)
14 diff
(96.8 %id)
BE830460 lung_tumor .a 1587 to 1985 413 to 16       398/413
(96 %)
0 diff
(100 %id)
BE837738 prostate_normal .a 1587 to 2000 1 to 424       424/434
(97 %)
24 diff
(94.5 %id)
BM977956 lung .a 1588 to 2254 679 to 14   AAA   666/666
(100 %)
1 diff
(99.9 %id)
BE717863 head_neck .a 1594 to 1992 12 to 411       400/411
(97 %)
6 diff
(98.6 %id)
AW149498 brain, medulloblastoma .a 1607 to 2256 657 to 7       651/657
(99 %)
0 diff
(100 %id)
BE837630 prostate_normal .a 1609 to 1993 389 to 5       385/389
(98 %)
0 diff
(100 %id)
CA428841 Bone, Subchondral Bone .a 1618 to 2257 658 to 19   AAA   640/640
(100 %)
1 diff
(99.9 %id)
AL044040 testis .a 1622 to 2224 603 to 1       603/603
(100 %)
0 diff
(100 %id)
BF842293 head_neck .a 1624 to 1920 1 to 297       297/297
(100 %)
11 diff
(96.3 %id)
BU581147 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .a 1640 to 2256 617 to 1       617/617
(100 %)
1 diff
(99.9 %id)
BM670142 eye, lens .a 1667 to 2257 606 to 16   fully sequenced, AAA   591/591
(100 %)
0 diff
(100 %id)
BE857201 brain, glioblastoma (pooled) .a 1682 to 2249 568 to 1       568/568
(100 %)
0 diff
(100 %id)
BE837804 prostate_normal .a 1688 to 2000 104 to 416       313/426
(73 %)
3 diff
(99.3 %id)
BE830553 lung_tumor .a 1699 to 1997 304 to 6       299/304
(98 %)
0 diff
(100 %id)
BE830491 lung_tumor .a 1700 to 2000 322 to 22       301/322
(93 %)
0 diff
(100 %id)
CB050758 Prostate .a 1702 to 2257 587 to 32   AAA   556/556
(100 %)
1 diff
(99.9 %id)
BE830511 lung_tumor .a 1703 to 1997 300 to 6       295/300
(98 %)
0 diff
(100 %id)
BI004241 head_normal .a 1717 to 1989 47 to 319       273/319
(85 %)
6 diff
(98.2 %id)
BI004302 head_normal .a 1718 to 1989 52 to 322       271/322
(84 %)
6 diff
(98.2 %id)
W88594 liver and spleen .a 1753 to 2013 1 to 265   fully sequenced,   265/265
(100 %)
0 diff
(100 %id)
AW612861 colon, moderately-differentiated adenocarcinoma .a 1756 to 2257 502 to 1       502/502
(100 %)
4 diff
(99.3 %id)
DB521903 testis .a 1762 to 2253 1 to 492     Submitted on the opposite strand 492/493
(99 %)
3 diff
(99.4 %id)
BM711637 eye, human retina .a 1762 to 2242 1 to 481   fully sequenced,   481/481
(100 %)
0 diff
(100 %id)
AI553977 pooled .a 1765 to 2258 497 to 4   tiling clone,   494/497
(99 %)
0 diff
(100 %id)
BF378205 uterus .a 1769 to 1874 109 to 1       109/109
(100 %)
4 diff
(96.4 %id)
BI040431 nervous_tumor .a 1772 to 2024 14 to 266       253/266
(95 %)
6 diff
(97.8 %id)
AV660436 corresponding non cancerous liver tissue .a 1774 to 2177 1 to 404     Submitted on the opposite strand 404/404
(100 %)
0 diff
(100 %id)
F29210 pectoral muscle (after mastectomy) .a 1775 to 2126 1 to 352       352/352
(100 %)
1 diff
(99.8 %id)
BF000820 malignant melanoma, metastatic to lymphnode, skin .a 1788 to 2254 466 to 1       466/602
(77 %)
15 diff
(97.6 %id)
AI817068 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 1790 to 2256 468 to 1       468/470
(99 %)
3 diff
(99.4 %id)
AI022220 liver and spleen .a 1805 to 2249 446 to 1       446/446
(100 %)
2 diff
(99.6 %id)
DB520818 testis .a 1808 to 2257 1 to 450     Submitted on the opposite strand 450/450
(100 %)
1 diff
(99.8 %id)
AA613730 Prostate, prostate tumor .a 1810 to 2258 457 to 9       449/457
(98 %)
0 diff
(100 %id)
F36762 pectoral muscle (after mastectomy) .a 1814 to 2222 1 to 409       409/409
(100 %)
0 diff
(100 %id)
F25178 pectoral muscle (after mastectomy) .a 1825 to 2248 1 to 424       424/424
(100 %)
0 diff
(100 %id)
AI961535 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1826 to 2254 429 to 1       429/429
(100 %)
0 diff
(100 %id)
W78098 heart .a 1832 to 2256 426 to 2       425/427
(99 %)
0 diff
(100 %id)
AI333482 lung .a 1837 to 2257 421 to 1       421/421
(100 %)
1 diff
(99.8 %id)
AI672702 thymus, pooled .a 1837 to 2256 421 to 2       420/421
(99 %)
0 diff
(100 %id)
AI923896 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1837 to 2254 418 to 1       418/418
(100 %)
0 diff
(100 %id)
AA402952 ovarian tumor, ovary .a 1839 to 2250 412 to 1     Submitted on the opposite strand 412/412
(100 %)
2 diff
(99.6 %id)
AA535716 colon .a 1839 to 2251 412 to 1       412/412
(100 %)
1 diff
(99.8 %id)
AA838686 parathyroid gland, parathyroid tumor .a 1840 to 2258 424 to 6       419/424
(98 %)
0 diff
(100 %id)
AF086420   .a 1841 to 2254 1 to 414   AAA   414/414
(100 %)
2 diff
(99.6 %id)
W79153 heart .a 1843 to 2256 15 to 434       420/434
(96 %)
6 diff
(98.7 %id)
BG819810 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1851 to 2257 1 to 407   AAA   407/407
(100 %)
0 diff
(100 %id)
AI400106 pooled .a 1858 to 2258 408 to 8       401/408
(98 %)
0 diff
(100 %id)
F34286 pectoral muscle (after mastectomy) .a 1861 to 2008 1 to 148       148/148
(100 %)
4 diff
(97.3 %id)
CN260675 embryonic stem cells, DMSO-treated H9 cellline .a 1871 to 2125 255 to 1     Submitted on the opposite strand 255/255
(100 %)
1 diff
(99.7 %id)
FN104206 breast carcinoma .a 1872 to 1966 1 to 98       98/98
(100 %)
5 diff
(94.9 %id)
AA085673 muscle, skeletal muscle .a 1878 to 2255 406 to 25       382/411
(92 %)
0 diff
(100 %id)
AA993708   .a 1884 to 2258 381 to 7       375/381
(98 %)
0 diff
(100 %id)
F33601 pectoral muscle (after mastectomy) .a 1891 to 2191 1 to 301       301/301
(100 %)
2 diff
(99.4 %id)
AI263573 Kidney .a 1904 to 2254 350 to 1       350/350
(100 %)
1 diff
(99.8 %id)
T33297 brain .a 1905 to 2254 351 to 1       351/351
(100 %)
1 diff
(99.8 %id)
T23988   .a 1912 to 2258 349 to 3       347/349
(99 %)
0 diff
(100 %id)
BU738186 eye, lens .a 1915 to 2254 358 to 19   fully sequenced, AAA   340/340
(100 %)
1 diff
(99.8 %id)
F36061 pectoral muscle (after mastectomy) .a 1918 to 2257 1 to 340   AAA   340/340
(100 %)
2 diff
(99.5 %id)
CN260673 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1920 to 2257 348 to 11   AAA Submitted on the opposite strand 338/338
(100 %)
3 diff
(99.2 %id)
AA857862 pharynx, squamous cell carcinoma .a 1924 to 2257 335 to 1       335/335
(100 %)
1 diff
(99.8 %id)
AI914597 colon .a 1925 to 2257 333 to 1       333/337
(98 %)
0 diff
(100 %id)
BF726105 eye, lens .a 1931 to 2254 366 to 43   AAA   324/324
(100 %)
2 diff
(99.4 %id)
H86606 eye, retina .a 1945 to 2254 316 to 1     Submitted on the opposite strand 316/318
(99 %)
10 diff
(96.9 %id)
BU730253 eye, human retina .a 1961 to 2257 312 to 16   fully sequenced, AAA   297/297
(100 %)
0 diff
(100 %id)
F24809 pectoral muscle (after mastectomy) .a 1971 to 2178 1 to 208       208/208
(100 %)
0 diff
(100 %id)
AA397396   .a 1974 to 2258 1 to 285       285/285
(100 %)
5 diff
(98.3 %id)
AI300053 2 pooled tumors (clear cell type), Kidney .a 1976 to 2256 283 to 3       281/283
(99 %)
0 diff
(100 %id)
W89094 liver and spleen .a 1983 to 2249 272 to 1   fully sequenced,   272/272
(100 %)
2 diff
(99.3 %id)
AA687775 normal prostate, Prostate .a 1986 to 2257 272 to 1       272/272
(100 %)
1 diff
(99.7 %id)
DB530288 hippocampus .a 1996 to 2255 1 to 261     Submitted on the opposite strand 261/263
(99 %)
5 diff
(98.1 %id)
T33693 brain .a 2019 to 2257 239 to 1       239/239
(100 %)
0 diff
(100 %id)
DC426785.
matches multiple genes
testis .a 2024 to 2254 232 to 1     also hits gene AFF1 232/232
(100 %)
1 diff
(99.6 %id)
AI868936 Prostate .a 2026 to 2254 258 to 30       229/258
(88 %)
0 diff
(100 %id)
AI758641 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 2049 to 2254 221 to 16   AAA   206/206
(100 %)
0 diff
(100 %id)
R84696 eye, retina .a 2050 to 2203 154 to 1     Submitted on the opposite strand 154/154
(100 %)
1 diff
(99.4 %id)
DB509869 testis .a 2052 to 2257 1 to 208     Submitted on the opposite strand 208/208
(100 %)
10 diff
(95.2 %id)
T24062   .a 2063 to 2258 199 to 3       197/199
(98 %)
0 diff
(100 %id)
AA025595 heart .a 2093 to 2257 166 to 1       166/168
(98 %)
3 diff
(98.3 %id)
GD136357   .a 2105 to 2258 1 to 154       154/168
(91 %)
6 diff
(96.5 %id)
C21165   .a 2129 to 2257 1 to 129       129/129
(100 %)
0 diff
(100 %id)
DB456488 testis .b 1 to 511 1 to 511   tiling clone,   511/511
(100 %)
8 diff
(98.5 %id)
NM_033271.2   .b 5 to 1982 1 to 1978 exact RefSeq, AAA   1978/1978
(100 %)
0 diff
(100 %id)
AF353674 lens .b 141 to 1982 1 to 1842   tiling clone, AAA   1842/1842
(100 %)
5 diff
(99.8 %id)
AI275634 placenta .b 146 to 666 1 to 521     Submitted on the opposite strand 521/521
(100 %)
0 diff
(100 %id)
AW028769 fibrotheoma, ovary .b 146 to 694 1 to 549     Submitted on the opposite strand 549/549
(100 %)
1 diff
(99.9 %id)
BF058081 fibrotheoma, ovary .b 146 to 893 1 to 748     Submitted on the opposite strand 748/750
(99 %)
16 diff
(97.9 %id)
AI492169 B-cell, chronic lymphotic leukemia .b 164 to 613 1 to 450     Submitted on the opposite strand 450/450
(100 %)
12 diff
(97.4 %id)
AI660790 thymus, pooled .b 173 to 661 1 to 489     Submitted on the opposite strand 489/489
(100 %)
4 diff
(99.2 %id)
AW237368 Kidney .b 173 to 808 1 to 636     Submitted on the opposite strand 636/636
(100 %)
12 diff
(98.2 %id)
AI554895 pooled .b 174 to 628 1 to 455     Submitted on the opposite strand 455/455
(100 %)
0 diff
(100 %id)
AI830608 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 176 to 743 1 to 567     Submitted on the opposite strand 567/567
(100 %)
3 diff
(99.5 %id)
AW027743 thymus, pooled .b 176 to 796 1 to 621     Submitted on the opposite strand 621/621
(100 %)
4 diff
(99.4 %id)
DR006515 Spleen .b 212 to 880 1 to 669       669/671
(99 %)
8 diff
(98.9 %id)
BU948479 insulinoma, Pancreas .b 225 to 652 1 to 428       428/428
(100 %)
6 diff
(98.6 %id)
DN992590 brain, whole brain .b 240 to 881 1 to 642       642/642
(100 %)
8 diff
(98.8 %id)
BX096412   .b 287 to 996 1 to 710       710/710
(100 %)
2 diff
(99.8 %id)
BQ953311 epidermoid carcinoma, cell line, lung .b 298 to 814 438 to 964       527/971
(54 %)
28 diff
(97.2 %id)
AA431886   .b 307 to 730 24 to 440       417/440
(94 %)
18 diff
(96.0 %id)
T08942   .b 356 to 679 1 to 324       324/324
(100 %)
0 diff
(100 %id)
CN260674 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 379 to 844 1 to 466       466/466
(100 %)
2 diff
(99.6 %id)
BG720309 testis .b 380 to 698 1 to 320       320/320
(100 %)
2 diff
(99.4 %id)
BG675897 skin, squamous cell carcinoma .b 386 to 1173 1 to 787       787/787
(100 %)
18 diff
(97.8 %id)
BU948211 insulinoma, Pancreas .b 1529 to 1987 475 to 17   AAA   459/459
(100 %)
1 diff
(99.8 %id)
AA431887   .b 1550 to 1991 444 to 4   tiling clone,   441/444
(99 %)
0 diff
(100 %id)
BM466059 embryonal carcinoma, cell line, testis .c 1 to 734 1 to 745   tiling clone,   745/1188
(62 %)
25 diff
(97.9 %id)
CF140034 CNCAP(3)T-225 cell line, Prostate .c 221 to 567 1 to 347       347/347
(100 %)
4 diff
(98.9 %id)
TI_154170379   .c 226 to 728 77 to 590       514/972
(52 %)
27 diff
(97.3 %id)
BU150266 dorsal root ganglia .c 228 to 1089 1 to 873   tiling clone,   873/923
(94 %)
15 diff
(98.4 %id)
TI_57221534   .c 238 to 1029 32 to 829       798/832
(95 %)
19 diff
(97.8 %id)
BF931745 nervous_tumor .c 240 to 607 371 to 1     Submitted on the opposite strand 371/371
(100 %)
11 diff
(97.1 %id)
BI757228 brain .c 240 to 1029 1 to 796   tiling clone,   796/799
(99 %)
13 diff
(98.4 %id)
T33694 brain .c 257 to 588 1 to 331       331/331
(100 %)
1 diff
(99.7 %id)
BM712327 eye, lens .c 266 to 813 1 to 548       548/548
(100 %)
3 diff
(99.5 %id)
EL594715 epidermis, skin .c 267 to 818 15 to 567       553/587
(94 %)
12 diff
(98.0 %id)
BM670994 eye, lens .c 1167 to 1744 596 to 19   tiling clone, AAA   578/578
(100 %)
1 diff
(99.9 %id)
AF173358 placenta Gene BTBD6, variant not shown         Suspected internal deletion, this clone was ignored    
BC042525 testis Gene BTBD6, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
BF057504 fibrotheoma, ovary Gene BTBD6, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
CN480310 Knee, Osteoarthritic Cartilage Gene BTBD6, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C